October 1, 2020
On Sept. 28, 2020, the Centers for Medicare and Medicaid Services approved the Medicaid state plan amendment to allow Texas HHS to enter into value-based agreements with drug manufacturers based on outcome data or other metrics. Agreements may include things of value, including, but not limited to:
- Rebate
- Discount
- Price reduction
- Contribution
- Risk sharing
- Reimbursement
- Payment deferral or installment payments
- Guarantee
- Patient care
- Shared savings payments
- Withholds
- Bonuses
Drug manufacturers interested in participating in this rebate program should complete and submit the Value-Based Agreement Concept (HHS Form 1402)
Tags:
Rebates